Cash Flow from Investing Activities (Annual)

Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.

Aurinia Pharmaceuticals Inc (AUPH) had Cash Flow from Investing Activities of $-32.77M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$283.06M
Net Income	$287.20M
Cost of Goods Sold	$32.66M
Gross Profit	$250.39M
Operating Expenses	$168.61M
Operating Income	$114.44M
Non-Operating Income/Expense	$-0.29M
Pre-Tax Income	$114.16M
Normalized Pre-Tax Income	$114.16M
Income after Taxes	$287.20M
Income from Continuous Operations	$287.20M
Consolidated Net Income/Loss	$287.20M
Normalized Income after Taxes	$287.20M
EBIT	$114.44M
EBITDA	$133.89M
Weighted-Average Shares Outstanding (Basic)	134.37M
Weighted-Average Shares Outstanding (Diluted)	138.70M
Earnings per Share (EPS) (Basic)	$2.14
Earnings per Share (EPS) (Diluted)	$2.07
Balance Sheet Financials
Current Assets	$491.97M
Property, Plant, and Equipment	$2.11M
Long-Term Assets	$259.62M
Total Assets	$751.59M
Current Liabilities	$93.72M
Long-Term Debt	$52.32M
Long-Term Liabilities	$76.53M
Total Liabilities	$170.26M
Common Equity	$581.33M
Tangible Shareholders Equity	$577.57M
Shareholders Equity	$581.33M
Common Shares Outstanding	132.32M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$135.66M
Cash Flow from Investing Activities	$-32.77M
Cash Flow from Financial Activities	$-106.11M
Beginning Cash	$83.43M
End Cash	$80.21M
Increase/Decrease in Cash	$-3.22M
Stock-Based Compensation	$14.68M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.25
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.08
Debt to Equity Ratio	0.12
Gross Margin	88.46%
Operating Margin	40.43%
EBIT Margin	40.43%
EBITDA Margin	47.30%
Pre-Tax Profit Margin	40.33%
Profit Margin	101.47%
Free Cash Flow	$135.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.38
Inventory Turnover	0.71
Receiveable Turnover	6.83
Days Sales in Receivables	53.45
Return on Equity	49.40%
Return on Tangible Equity	49.73%
Return on Assets	38.21%
Return on Investments	45.32%
Book Value Per Share	$4.39
Free Cash Flow per Share	$0.98
Operating Cash Flow per Share	$0.98

Data from Zacks Investment Research, Inc.